ENZO BIOCHEM INC ENZ (NYSE) $ 4.67 Change: -0.21 -4.5% | Volume: 162,079
Sponsored by Click here!

ENZO BIOCHEM - Fundamental Profile

Company Information

Ticker Symbol: ENZ
Exchange: NYSE
Contact Info: 527 Madison Avenue New York NY 10022 212-583-0100
CEO/President: Elazar Rabbani Ph.D.
Industry: Medical - Biomedical / Standard Industry Code: 8071
Description: Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company\'s three wholly-owned subsidiaries--Enzo Diagnostics, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc. The primary focus of the company\'s research is the development of products based on two technology platforms -- genetic modulation and immune modulation.

Share Information

Shares Outstanding: 37,210 (000) Market Value: 182,420 ($000)
Percentage of Inst.Shareholders: 47.97% Number of Inst.Shareholders: 18.74%
Last Quarter Sales: 21.18 ($Mil.) Last Quarter Net Income: -3.26 ($Mil.)
Last Quarter EPS: -0.09 P/E Ratio: 0
Most Recent Earnings: 0.04 on 06/16/03 Earnings Per Share: -0.29
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: 1.050 on 10/21/04 Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

AMGEN INC. +9.10 56.09
GILEAD SCIENCES -1.80 45.91
CELGENE CORPORA -8.00 58.56
BIOGEN IDEC INC -31.90 43.13
STEMCELLS INC. -56.40 1.23